Literature DB >> 8897580

Glycosaminoglycans, proteins, and stone formation: adult themes and child's play.

R L Ryall1.   

Abstract

The relative infrequency of renal stones in children is probably the main reason for the paucity of literature devoted to the study of urolithiasis in pediatric patients. Nonetheless, when pediatricians do address the issue, the contents of their papers reflect those prevalent in the adult literature; with one notable exception. Papers dealing with the potential role of urinary macromolecules in pediatric stone disease are very scarce indeed; to my knowledge, only four have been published in the English literature in the last 15 years. One of these is to be found in this issue and, like the remaining three, it compares the urinary excretion of glycosaminoglycans in healthy children and those with stones. This article briefly reviews the history of the association of urinary macromolecules, particularly glycosaminoglycans and proteins, with calcium oxalate urolithiasis, and discusses in more detail the published experimental evidence for their fulfilling a determinant role in stone formation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8897580     DOI: 10.1007/s004670050185

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  122 in total

1.  Molecular abnormality of urinary glycoprotein crystal growth inhibitor in calcium nephrolithiasis.

Authors:  Y Nakagawa; J H Parks; F J Kézdy; F L Coe
Journal:  Trans Assoc Am Physicians       Date:  1985

2.  Isolation and characterization of calcium oxalate crystal growth inhibitors from human urine.

Authors:  Y Nakagawa; E T Kaiser; F L Coe
Journal:  Biochem Biophys Res Commun       Date:  1978-10-30       Impact factor: 3.575

3.  Childhood urolithiasis: experiences and advances.

Authors:  J P Gearhart; G Z Herzberg; R D Jeffs
Journal:  Pediatrics       Date:  1991-04       Impact factor: 7.124

4.  Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis.

Authors:  Y Nakagawa; V Abram; J H Parks; H S Lau; J K Kawooya; F L Coe
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

5.  Blood coagulation proteins and urolithiasis are linked: crystal matrix protein is the F1 activation peptide of human prothrombin.

Authors:  A M Stapleton; R L Ryall
Journal:  Br J Urol       Date:  1995-06

6.  A study of glycosaminoglycan excretion in normal and stone-forming subjects using a modified cetylpyridinium chloride technique.

Authors:  C T Samuell
Journal:  Clin Chim Acta       Date:  1981-11-25       Impact factor: 3.786

7.  Ultrastructural localization of Tamm-Horsfall protein in human kidney using immunogold electron microscopy.

Authors:  R J Peach; W A Day; P J Ellingsen; A R McGiven
Journal:  Histochem J       Date:  1988-03

Review 8.  Pediatric urolithiasis: review of research and current management.

Authors:  E P Harmon; D E Neal; R Thomas
Journal:  Pediatr Nephrol       Date:  1994-08       Impact factor: 3.714

9.  Characterization of uronic-acid-rich inhibitor of calcium oxalate crystallization isolated from rat urine.

Authors:  F Atmani; S R Khan
Journal:  Urol Res       Date:  1995

10.  Matrix glycosaminoglycan in urinary stones.

Authors:  S Nishio; Y Abe; A Wakatsuki; H Iwata; K Ochi; M Takeuchi; A Matsumoto
Journal:  J Urol       Date:  1985-09       Impact factor: 7.450

View more
  10 in total

Review 1.  Pediatric urolithiasis: etiology, specific pathogenesis and medical treatment.

Authors:  K Sarica
Journal:  Urol Res       Date:  2006-01-24

2.  Identification of human urinary trefoil factor 1 as a novel calcium oxalate crystal growth inhibitor.

Authors:  Somchai Chutipongtanate; Yasushi Nakagawa; Suchai Sritippayawan; Jeeraporn Pittayamateekul; Paisal Parichatikanond; Bruce R Westley; Felicity E B May; Prida Malasit; Visith Thongboonkerd
Journal:  J Clin Invest       Date:  2005-11-23       Impact factor: 14.808

Review 3.  Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation.

Authors:  R L Ryall
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

4.  Kinetics of calcium oxalate crystal formation in urine.

Authors:  Norbert Laube; Florian Klein; Falk Bernsmann
Journal:  Urolithiasis       Date:  2016-06-21       Impact factor: 3.436

5.  Toward a structure determination method for biomineral-associated protein using combined solid- state NMR and computational structure prediction.

Authors:  David L Masica; Jason T Ash; Moise Ndao; Gary P Drobny; Jeffrey J Gray
Journal:  Structure       Date:  2010-12-08       Impact factor: 5.006

6.  Stress-stones-stress-recurrent stones: a self-propagating cycle? Difficulties in solving this dichotomy.

Authors:  Montserrat Arzoz-Fabregas; Josep Roca-Antonio; Luis Ibarz-Servio; Dalielah Jappie-Mahomed; Allen Rodgers
Journal:  Urolithiasis       Date:  2017-03-21       Impact factor: 3.436

7.  Variability of protein content in calcium oxalate monohydrate stones.

Authors:  James C Williams; Chad A Zarse; Molly E Jackson; Frank A Witzmann; James A McAteer
Journal:  J Endourol       Date:  2006-08       Impact factor: 2.942

Review 8.  The role of macromolecules in the formation of kidney stones.

Authors:  Jeffrey D Rimer; Ann M Kolbach-Mandel; Michael D Ward; Jeffrey A Wesson
Journal:  Urolithiasis       Date:  2016-12-02       Impact factor: 3.436

9.  A novel calcium oxalate crystal growth inhibitory protein from the seeds of Dolichos biflorus (L.).

Authors:  Rakesh K Bijarnia; Tanzeer Kaur; Surinder K Singla; Chanderdeep Tandon
Journal:  Protein J       Date:  2009-05       Impact factor: 2.371

Review 10.  Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators.

Authors:  Kanu Priya Aggarwal; Shifa Narula; Monica Kakkar; Chanderdeep Tandon
Journal:  Biomed Res Int       Date:  2013-09-14       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.